Vigilance for Medical Products of Human Origin-Progress on the Notify Library's Global Effort to Share Information and Learning.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
pubmed:
16
1
2021
medline:
3
11
2021
entrez:
15
1
2021
Statut:
ppublish
Résumé
World Health Assembly Resolution 63.22 mandated World Health Organization to facilitate Member State access to appropriate information on medical products of human origin (MPHO), including collecting data on serious adverse events and reactions. To meet this challenge, the Italian National Transplant Center, with a mandate from World Health Organization, has built and maintained an open-access searchable database of instructive records on disease transmission and other MPHO adverse occurrences. One record in the Notify Library describes a specific type of adverse occurrence in 1 type of MPHO and might be linked with 1 or multiple different references. The record inclusion criteria are that it has been reliably documented in a published article or official vigilance reporting system and that it has instructive value for the fields of transfusion, transplantation, or assisted reproduction. The selection and review of references for publication is performed by international experts who collaborate in 5 topic-specific editorial groups: infection transmission, malignancy transmission, living-donor reactions, process-related incidents, and clinical complications. New relevant references are identified through systematic searches and proactive communication by the experts. The Library contains 1733 records, quoting 2632 references. Of the records, 41.8% are related to organs, 20.8% to blood and blood components, 16.5% to hematopoietic progenitor cells, 15.2% to tissues, 4.2% to reproductive tissues and cells, and 1.5% to other MPHO. Notify Library is the first open-access, searchable database of systematically identified reports of disease transmission and other adverse occurrences arising from the donation and clinical application of MPHO.
Sections du résumé
BACKGROUND
World Health Assembly Resolution 63.22 mandated World Health Organization to facilitate Member State access to appropriate information on medical products of human origin (MPHO), including collecting data on serious adverse events and reactions. To meet this challenge, the Italian National Transplant Center, with a mandate from World Health Organization, has built and maintained an open-access searchable database of instructive records on disease transmission and other MPHO adverse occurrences.
METHODS
One record in the Notify Library describes a specific type of adverse occurrence in 1 type of MPHO and might be linked with 1 or multiple different references. The record inclusion criteria are that it has been reliably documented in a published article or official vigilance reporting system and that it has instructive value for the fields of transfusion, transplantation, or assisted reproduction. The selection and review of references for publication is performed by international experts who collaborate in 5 topic-specific editorial groups: infection transmission, malignancy transmission, living-donor reactions, process-related incidents, and clinical complications. New relevant references are identified through systematic searches and proactive communication by the experts.
RESULTS
The Library contains 1733 records, quoting 2632 references. Of the records, 41.8% are related to organs, 20.8% to blood and blood components, 16.5% to hematopoietic progenitor cells, 15.2% to tissues, 4.2% to reproductive tissues and cells, and 1.5% to other MPHO.
CONCLUSIONS
Notify Library is the first open-access, searchable database of systematically identified reports of disease transmission and other adverse occurrences arising from the donation and clinical application of MPHO.
Identifiants
pubmed: 33449611
doi: 10.1097/TP.0000000000003589
pii: 00007890-202109000-00013
pmc: PMC8376274
doi:
Substances chimiques
Biological Products
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1921-1929Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors declare no funding or conflicts of interest.
Références
Notify Library. The NOTIFY guide on vigilance and surveillance: vigilance and surveillance (V&S) of medical products of human origin (MPHO). Notify Library: the global vigilance and surveillance database for medical products of human origin . 2018. Available at https://www.notifylibrary.org/content/booklet-2018 . Accessed August 24, 2020.
WHO Expert Group. Expert Consensus Statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD). Vox Sang. 2012;103:337–342.
Fehily D, Strong DM, Minutoli D, et al. Sharing vigilance experience and knowledge globally: a preliminary overview of the Notify Library. Cells Tissues Organs. 2013;16:117–125.
Strong DM. Tissue banking, biovigilance and the notify library. Cell Tissue Bank. 2018;19:187–195.
World Health Organization. WHO guiding principles on human cell, tissue and organ transplantation. Transplantation. 2010;90:229–233.
Notify. Notify Exploring Vigilance Notification for Organs, Tissues and Cells. Editrice Compositori; 2011.
World Health Organization. WHO consultation on vigilance and surveillance for medical products of human origin notify project—First Technical Meeting, 23-25 February 2015, Barcelona, Spain . 2015. Available at https://www.notifylibrary.org/sites/default/files/REPORT%20BARCELONA%202015.pdf . Accessed August 25, 2020.
Ison MG, Nalesnik MA. An update on donor-derived disease transmission in organ transplantation. Am J Transplant. 2011;11:1123–1130.
SOHO V&S Public Health. SOHO V&S guidance for competent authorities: communication and investigation of serious adverse events and reactions associated with human tissues and cells . 2013. Available at https://www.notifylibrary.org/sites/default/files/SOHO%20V%26S%20Communication%20and%20Investigation%20Guidance.pdf . Accessed December 4, 2020.
ISBT Working Party on Haemovigilance. Proposed standard definitions for surveillance of non infectious adverse transfusion reactions, incorporating correction to TRALI definition (as adopted June 2013 ). 2013. Available at http://www.notifylibrary.org/sites/default/files/Proposed%20Definitions%20for%20surveillance%20of%20non%20infectious%20adverse%20transfusion%20reactions%202011-2013_0.pdf . Accessed December 4, 2020.
Boyle SM, Ali N, Olszanski AJ, et al. Donor-derived metastatic melanoma and checkpoint inhibition. Transplant Proc. 2017;49.
Foster MA, Weil LM, Jin S, et al. Transmission of hepatitis A virus through combined liver-small intestine-pancreas transplantation. Emerg Infect Dis. 2017;23:590–596.
Hermans F, Ombelet S, Degezelle K, et al. First-in-man observation of Talaromyces marneffei-transmission by organ transplantation. Mycoses. 2017;60:213–217.
Schlottau K, Forth L, Angstwurm K, et al. Fatal encephalitic borna disease virus 1 in solid-organ transplant recipients. N Engl J Med. 2018;379:1377–1379.
Cheng VCC, Sridhar S, Wong SC, et al. Japanese encephalitis virus transmitted via blood transfusion, Hong Kong, China. Emerg Infect Dis. 2018;24:49–57.
Hinsenkamp M, Muylle L, Eastlund T, et al. Adverse reactions and events related to musculoskeletal allografts: reviewed by the World Health Organisation Project NOTIFY. Int Orthop. 2012;36:633–641.
Dubord PJ, Evans GD, Macsai MS, et al. Eye banking and corneal transplantation communicable adverse incidents: current status and project NOTIFY. Cornea. 2013;32:1155–1166.
Gandhi MJ, Strong DM, Whitaker BI, et al. A brief overview of clinical significance of blood group antibodies. Immunohematology. 2018;33:4–6.
Whitaker BI, Strong DM, Gandhi MJ, et al. Hemovigilance and the notify library. Immunohematology. 2017;33:159–164.
European Commission Public Health Programme. Vigilance and Inspection for the Safety of Transfusion, Assisted Reproduction and Transplantation (VISTART—GA676969) joint action . 2017. Available at https://webgate.ec.europa.eu/chafea_pdb/health/projects/676969/summary . Accessed August 25, 2020.
VISTART. A user guide for competent authority. EU VISTART JA (GA/676969 ). 2019. Available at https://www.notifylibrary.org/sites/default/files/VISTART_WP5A_A%20User%20Guide%20for%20CA.pdf . Accessed August 2020.
Petrisli E, Noel L, Schnitzler J, et al. Horizon scanning through media mining to identify medical products of human origin-associated infectious risks: preliminary results of a pilot Notify Project study. Blood Transfus. 2016;14(suppl 1):s37.
Recommendations for epidemic disease occurrence . 2020. Available at https://www.notifylibrary.org/background-documents#SARS-CoV-2 . Accessed December 4, 2020.